Cancer treatment reports

publication venue for

Phase I trial of homoharringtonine in children with refractory leukemia.. 71. 1987
Improved survival of infants less than 1 year of age with acute lymphoblastic leukemia treated with intensive multiagent chemotherapy.. 71. 1987
Inadequacy of predicted creatinine clearance as guide to chemotherapy.. 71. 1987
Pharmacokinetics of continuous-infusion high-dose thiotepa.. 71. 1987
Gallium nitrate in prostatic cancer: evaluation of antitumor activity and effects on bone turnover.. 71. 1987
Phase II trial of mitomycin in malignant mesothelioma.. 71. 1987
Phase II trial of idarubicin in patients with pancreatic cancer.. 71. 1987
Phase II trial of ifosfamide and mesna in advanced colorectal cancer.. 71. 1987
Phase I-II study of eflornithine and mitoguazone combined in the treatment of recurrent primary brain tumors.. 71. 1987
Phase II trial of cisplatin and etoposide in adenocarcinomas of the upper gastrointestinal tract.. 71. 1987
Phase II trial of etoposide in APUD tumors.. 71. 1987
Phase II trial of carboplatin in patients with advanced germ cell tumors refractory to cisplatin.. 71. 1987
Prolonged unmaintained remission after intensive consolidation therapy in adult acute nonlymphocytic leukemia.. 71. 1987
High-dose human lymphoblastoid interferon in metastatic colorectal cancer: clinical results and modification of biological responses.. 71. 1987
Phase II trial of esorubicin in patients with advanced non-small cell lung cancer.. 71. 1987
Phase II trial of oral piritrexim (BW301U) in patients with stage III non-small cell lung cancer.. 71. 1987
Teniposide in the treatment of non-small cell lung carcinoma.. 71. 1987
Phase II trial of dichloromethotrexate in epidermoid carcinoma of the esophagus.. 70. 1986
Phase II trial of esorubicin in patients with advanced colorectal carcinoma.. 70. 1986
Trial of the combination of mitomycin, vindesine, and cisplatin in patients with advanced non-small cell lung cancer.. 70. 1986
Northern California Oncology Group protocol 6G91: response to treatment with radiation therapy and seven-drug chemotherapy in patients with glioblastoma multiforme.. 70. 1986
Phase II trial of N-methylformamide in patients with advanced colorectal carcinoma.. 70. 1986
I.v. infusion of opioids for cancer pain: clinical review and guidelines for use.. 70. 1986
Phase I trial of recombinant interferon gamma by 1-hour i.v. infusion.. 70. 1986
Phase I trial of taxol given as a 3-hour infusion every 21 days.. 70. 1986
Phase II trial of N-methylformamide for advanced renal cell carcinoma.. 70. 1986
Cisplatin, vindesine, and mitoguazone in the treatment of esophageal cancer.. 70. 1986
The Norton-Simon hypothesis revisited.. 70. 1986
Phase II trial of carboplatin in patients with adenocarcinomas of the upper gastrointestinal tract.. 69. 1985
Carboplatin: a new platinum analog in the treatment of epidermoid carcinoma of the esophagus.. 69. 1985
Consecutive dose-finding trials adding lorazepam to the combination of metoclopramide plus dexamethasone: improved subjective effectiveness over the combination of diphenhydramine plus metoclopramide plus dexamethasone.. 69. 1985
Adenocarcinoma of unknown primary origin: treatment with vindesine and doxorubicin.. 69. 1985
Cisplatin-containing chemotherapy in the treatment of invasive thymoma: report of five cases.. 69. 1985
Metabolic effects of gallium nitrate administered by prolonged infusion.. 69. 1985
Phase II trial of high-dose cisplatin in patients with malignant mesothelioma.. 69. 1985
Six-drug chemotherapy (hexamethylmelamine, doxorubicin, cisplatin, cyclophosphamide, methotrexate, and 5-FU; CHAMP-5) for ovarian carcinoma: alternating sequences of combination regimens.. 69. 1985
Treatment of refractory Hodgkin's disease with teniposide, cisplatin, hexamethylmelamine, and prednisolone: cancer and leukemia group B trial 8171.. 69. 1985
Treatment of advanced endometrial carcinoma with doxorubicin and cisplatin: effects on both untreated and previously treated patients.. 69. 1985
Phase II trial of 1,2-diaminocyclohexane-(4-carboxyphthalato) platinum(II) in patients with refractory germ cell tumors.. 69. 1985
Phase II trial of mitoguazone in patients with refractory germ cell tumors.. 69. 1985
Randomized trial comparing vindesine plus cisplatin with vinblastine plus cisplatin in patients with non-small cell lung cancer, with an analysis of methods of response assessment.. 69. 1985
N-methylformamide-induced hypophosphatemia.. 69. 1985
Phase I evaluation and pharmacokinetic study of weekly iv thymidine and 5-FU in patients with advanced colorectal carcinoma.. 69. 1985
Intravesical administration of bacillus Calmette-Guérin in patients with recurrent superficial carcinoma of the urinary bladder: report of a prospective, randomized trial.. 69. 1985
Phase I-II trial of mitoxantrone in acute leukemia.. 69. 1985
Phase II trial of 4'-epi-doxorubicin in advanced carcinoma of head and neck origin.. 69. 1985
Phase II study of 4-demethoxydaunorubicin in patients with adenocarcinoma of the upper gastrointestinal tract.. 68. 1984
Phase II trial of 13-cis-retinoic acid in patients with advanced nonseminomatous germ cell tumors.. 68. 1984
Phase II trial of mitoguazone in patients with advanced head and neck cancer.. 68. 1984
Phase II evaluation of metoprine in advanced pancreatic adenocarcinoma.. 68. 1984
Phase II trial of 4'-epi-doxorubicin in patients with advanced malignant melanoma.. 68. 1984
Phase II trial of 4-demethoxydaunorubicin in advanced colorectal carcinoma.. 68. 1984
Phase I evaluation of a biochemically designed combination: PALA, thymidine, and 5-FU.. 68. 1984
Phase II trial of mitoguazone in patients with relapsed small cell carcinoma of the lung.. 68. 1984
Antiemetic therapy: a review of recent studies and a report of a random assignment trial comparing metoclopramide with delta-9-tetrahydrocannabinol.. 68. 1984
Diagnosis of and therapy for solid tumors with radiolabeled antibodies and immune fragments.. 68. 1984
Phase I trial of PCNU.. 67. 1983
Phase II trial of PCNU in non-small cell lung cancer.. 67. 1983
Vindesine in the treatment of malignant mesothelioma: a phase II study.. 67. 1983
Phase II trial of 4'-epi-doxorubicin in patients with non-small cell lung cancer.. 67. 1983
Cisplatin for adrenal cortical carcinoma.. 67. 1983
Phase II trial of etoposide in adenocarcinomas of the upper gastrointestinal tract.. 67. 1983
Phase II study of etoposide in the treatment of esophageal carcinoma.. 67. 1983
Ip cisplatin in patients with malignant ascites: pharmacokinetic evaluation and comparison with the iv route.. 67. 1983
Phase II trial of bisantrene in advanced colorectal carcinoma.. 67. 1983
Induction chemotherapy with cisplatin and cyclophosphamide and maintenance chemotherapy with doxorubicin and 5-FU in advanced urinary bladder tumors.. 67. 1983
Phase II trial of PALA in hypernephroma and urinary bladder cancer.. 66. 1982
Phase II evaluation of 4'-epi-doxorubicin in patients with advanced colorectal carcinoma.. 66. 1982
Phase II trial of bisantrene for advanced hypernephroma.. 66. 1982
Phase II trial of spirogermanium in advanced epithelial carcinoma of the ovary.. 66. 1982
Phase II trial of AMSA in previously treated patients with stage III and IV ovarian cancer.. 66. 1982
Phase II study of methyl-GAG in the treatment of esophageal carcinoma.. 66. 1982
Multidisciplinary treatment of advanced Hodgkin's disease by an alternating chemotherapeutic regimen of MOPP/ABDV and low-dose radiation therapy restricted to originally bulky disease.. 66. 1982
Cardiac abnormalities after AMSA administration.. 66. 1982
Cisplatin, doxorubicin, cyclophosphamide, and vindesine combination chemotherapy for non-small cell lung cancer.. 66. 1982
Cisplatin, vindesine, and bleomycin (DVB) combination chemotherapy for esophageal carcinoma.. 65. 1981
Phase II study of vinblastine-CCNU, triazinate, and dactinomycin in advanced renal cell cancer.. 65. 1981
Treatment of renal carcinoma: a phase III randomized trial of oral medroxyprogesterone (Provera), hydroxyurea, and nafoxidine.. 65. 1981
Combination chemotherapy salvage of heavily pretreated patients with Hodgkin's disease: an analysis of prognostic factors in two chemotherapy trials and the literature.. 65. 1981
A prospective randomized study of adjuvant parenteral nutrition in the treatment of diffuse lymphoma: effect on drug tolerance.. 65 Suppl 5. 1981
Kinetic and cytotoxic effects of cytarabine and daunorubicin on cells in culture.. 65. 1981
Nitrogen metabolism in cancer patients.. 65 Suppl 5. 1981
Phase II evaluation of metoprine in patients with advanced colorectal carcinoma.. 65. 1981
Regional blood flow, capillary permeability, and glucose utilization in two brain tumor models: preliminary observations and pharmacokinetic implications.. 65 Suppl 2. 1981
Stereotactic interstitial irradiation for the treatment of brain tumors.. 65 Suppl 2. 1981
The impact of malnutrition on treatment results in breast cancer.. 65 Suppl 5. 1981
Total parenteral nutrition in a methylcholanthrene-induced rat sarcoma model.. 65 Suppl 5. 1981
Phase II evaluation of 4'-(9-acridinylamino)-methanesulfon-m-anisidide (AMSA) in patients with advanced colorectal carcinoma.. 64. 1980
Phase II evaluation of N-(phosphonacetyl)-L-aspartic acid (PALA) in patients with non-small cell carcinoma of the lung.. 64. 1980
Phase II evaluation of 4'-(9-acridinylamino)methanesulfon-m-anisidide (AMSA) in patients with non-small cell lung cancer.. 64. 1980
Phase II evaluation of N-(phosphonacetyl-L-aspartic acid (PALA) in patients with advanced colorectal carcinoma.. 64. 1980
Prognostic factors in cancer of the testis: an approach to identification.. 64. 1980
Vinblastine, intermittent bleomycin, and single-dose cis-dichlorodiammineplatinum(II) in the management of stge III testicular cancer.. 64. 1980
Phase I evaluation of 4'-(9-acridinylamino)methanesulfon-m-anisidide (AMSA) by a weekly iv dose schedule.. 64. 1980
Phase II trial of 4'-(9-acridinylamino)methanesulfon-m-anisidide (AMSA) in patients with metastatic hypernephroma.. 64. 1980
Randomized clinical trial comparing two dose regimens of ICRF-159 in refractory malignant lymphomas.. 64. 1980
Phase II evaluation of vindesine in patients with advanced colorectal carcinoma.. 63. 1979
Phase II study of high-dose cis-dichlorodiammineplatinum(II) in the treatment of non-small cell lung cancer.. 63. 1979
Platinum concentrations in bile and plasma following rapid and 6-hour infusions of cis-dichlorodiammineplatinum(II).. 63. 1979
Vindesine in the treatment of esophageal carcinoma: a phase II study.. 63. 1979
Chemotherapy for advanced germinal cell neoplasms: preliminary report of an Eastern Cooperative Oncology Group Study.. 63. 1979
Thymidine and thymine in biologic fluids during high-dose infusions of thymidine in mice, monkeys, and man.. 63. 1979
Electron-beam therapy for mycosis fungoides: the Stanford University experience.. 63. 1979
Experience with lymphography in patients with mycosis fungoides.. 63. 1979
Radiation therapy in the management of cutaneous T-cell lymphomas.. 63. 1979
Status report of 376 mycosis fungoides patients at 4 years: Mycosis Fungoides Cooperative Group.. 63. 1979
Phase II evaluation of pyrazofurin in patients with advanced colorectal carcinoma.. 63. 1979
VM-26, a new anticancer drug with effectiveness in malignant lymphoma: an Eastern Cooperative Oncology Group Study (EST 1474).. 63. 1979
cis-Dichlorodiammineplatinum(II)-based chemotherapy as initial treatment of advanced head and neck cancer.. 63. 1979
cis-Dichlorodiammineplatinum(II) and adriamycin treatment of advanced ovarian cancer.. 62. 1978
Randomized trial of levamisole in patients with squamous cancer of the head and neck: a preliminary report.. 62. 1978
Lack of therapeutic synergism between vincristine and methotrexate in L1210 murine leukemia in vivo.. 62. 1978
cis-Dichlorodiammineplatinum(II) and bleomycin in the treatment of esophageal carcinomas.. 62. 1978
Phase II study of 2,2'-anhydro-1-beta-D-arabinofuranosyl-5-fluorocytosine in advanced colorectal carcinoma.. 62. 1978
Comparison of adriamycin with cyclophosphamide in patients with advanced endometrial cancer.. 62. 1978
Iv methyl-CCNU, VM-26, and cranial irradiation in therapy for malignant brain tumors.. 61. 1977
Piperazinedione in metastatic renal carcinoma.. 61. 1977
Tumor size, sensitivity to therapy, and design of treatment schedules.. 61. 1977
Advanced lymphocytic lymphoma: randomized comparisons of chemotherapy and radiotherapy, alone or in combination.. 61. 1977
Combination chemotherapy in non-Hodgkin's lymphoma: results of long-term followup.. 61. 1977
Peritoneoscopy: a technique to evaluate therapeutic efficacy in non-Hodgkin's lymphoma patients.. 61. 1977
Treatment of malignant meningeal disease with intrathecal thioTEPA: a phase II study.. 61. 1977
Comparative effects of folate antagonists versus enzymatic folate depletion on folate and thymidine enzymes in cultured mammalian cells.. 61. 1977
Distribution of methotrexate in the cerebrospinal fluid and brain after intraventricular administration.. 61. 1977
Methotrexate, cytosine arabinoside, and BCNU concentration in brain after ventriculocisternal perfusion.. 61. 1977
CIS-Dichlorodiammineplatinum(II) in the treatment of epidermoid carcinoma of the head and neck.. 61. 1977
Cyclophosphamide L2 protocol: a combination chemotherapeutic regimen for advanced non-hodgkin's lymphoma.. 61. 1977
Physical-chemical characterization of living cells by laser-flow microfluorometry.. 60. 1976
Eight-drug combination chemotherapy (MOPP and ABDV) and local radiotherapy for advanced Hodgkin's Disease.. 60. 1976
Noninvasive monitoring of adriamycin cardiotoxicity by "Sphygmo-Recording" of the pulse wave delay (QKd interval).. 60. 1976
Is further intensification of treatment warranted in acute nonlymphoblastic leukemia?. 67. 1983

VIVO Weill Cornell Medical College

Cancer treatment reports Journal

Overview

publication venue for

Identity

ISO Abbreviation

Linking ISSN

International Standard Serial Number (ISSN)